Literature DB >> 2953093

Correction of lysosomal enzyme deficiency in various organs of beta-glucuronidase-deficient mice by allogeneic bone marrow transplantation.

P M Hoogerbrugge, B J Poorthuis, A H Mulder, G Wagemaker, L J Dooren, J M Vossen, D W van Bekkum.   

Abstract

The correction of lysosomal enzyme deficiency was investigated for various organs of beta-glucuronidase-deficient C3H/Rij mice after allogeneic bone marrow transplantation from an enzymatically normal donor strain (C57BL/Rij). In the hemopoietic organs, the enzyme level increased to levels found in donor mice. In lung, kidney, liver, and peripheral nervous tissue, a significant increase in enzyme activity was seen to levels intermediate between those of donor and recipient. Increased enzyme activity was maintained throughout the observation period of 150 days. In skeletal muscle tissue, enzyme levels tended to be higher in recipient mice, but this increase was not significant for all data points. Bone marrow transplantation failed to significantly affect enzyme activity in central nervous system tissue. These data suggest that beneficial effects expected from bone marrow transplantation for lysosomal enzyme deficiencies depend on the type of tissue involved in the disease. In diseases severely affecting the central nervous system, cure may not be expected from bone marrow transplantation alone, whereas in diseases with only minimal central nervous system involvement, alleviation or prevention of clinical symptoms may occur.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953093     DOI: 10.1097/00007890-198705000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

Review 2.  Lysosomal storage diseases: mechanisms of enzyme replacement therapy.

Authors:  G Bou-Gharios; D Abraham; I Olsen
Journal:  Histochem J       Date:  1993-09

3.  Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT).

Authors:  B E Wojcik; H A Jinnah; C E Muller-Sieburg; T Friedmann
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

4.  Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer.

Authors:  T Li; B L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse.

Authors:  P M Hoogerbrugge; B J Poorthuis; A E Romme; J J van de Kamp; G Wagemaker; D W van Bekkum
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.

Authors:  E H Birkenmeier; M T Davisson; W G Beamer; R E Ganschow; C A Vogler; B Gwynn; K A Lyford; L M Maltais; C J Wawrzyniak
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Long-term effects of bone marrow transplantation on lysosomal enzyme replacement in beta-glucuronidase-deficient mice.

Authors:  G Bou-Gharios; G Adams; P Pace; I Olsen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero.

Authors:  Norimasa Ihara; Umezawa Akihiro; Naoko Onami; Hideki Tsumura; Eisuke Inoue; Satoshi Hayashi; Haruhiko Sago; Shuki Mizutani
Journal:  Congenit Anom (Kyoto)       Date:  2015-02       Impact factor: 1.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.